Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Roman Weger"'
Autor:
Jens Lehmann, Kelly M de Ligt, Stefanie Tipelius, Johannes M Giesinger, Monika Sztankay, Sandra Voigt, Lonneke V van de Poll-Franse, Gerhard Rumpold, Roman Weger, Ella Willenbacher, Wolfgang Willenbacher, Bernhard Holzner
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e46017 (2023)
BackgroundThe use of software to monitor patient-reported outcome measures (PROMs) can improve outcomes for patients with cancer receiving anticancer therapy; however, evidence from applications used in routine clinical practice is lacking. Objectiv
Externí odkaz:
https://doaj.org/article/d1ce355254d6460e833e2247a1fdc702
Autor:
Karin A. Koinig, Christoph Arnold, Jens Lehmann, Johannes Giesinger, Stefan Köck, Wolfgang Willenbacher, Roman Weger, Bernhard Holzner, Ute Ganswindt, Dominik Wolf, Reinhard Stauder
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3928-3937 (2021)
Abstract Background To permit timely mitigation of adverse effects on overall clinical outcome, it is essential to understand how the pandemic influences distress and health‐related quality of life (HRQOL) in cancer patients during the coronavirus
Externí odkaz:
https://doaj.org/article/b6b4462dc6184c4fad619df0210a831e
Autor:
Marlies Antlanger, Tobias Dust, Thomas Reiter, Alexandra Böhm, Wolfgang W. Lamm, Max Gornicec, Ella Willenbacher, David Nachbaur, Roman Weger, Werner Rabitsch, Susanne Rasoul-Rockenschaub, Nina Worel, Daniel Lechner, Hildegard Greinix, Felix Keil, Heinz Gisslinger, Hermine Agis, Maria-Theresa Krauth
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Renal impairment (RI) is a negative prognostic factor in Multiple Myeloma (MM) and affected patients are often excluded from autologous stem cell transplantation (ASCT). However, it remains unclear whether historically inferior ou
Externí odkaz:
https://doaj.org/article/772b7712f7614189872822ebf719be5b
Autor:
Ella Willenbacher, Roman Weger, Ursula Rochau, Uwe Siebert, Wolfgang Willenbacher, Austrian Myeloma Registry (AMR)
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0147381 (2016)
OBJECTIVE:Clinical trials demonstrate improving survival in patients with multiple myeloma (MM) after treatment. However, it is unclear whether increased survival translates to a similar benefit in a real world setting. METHODS:We analyzed the overal
Externí odkaz:
https://doaj.org/article/2aa5eb124e6848b0b864824dc114bddc
Autor:
Jens Lehmann, Kelly M de Ligt, Stefanie Tipelius, Johannes M Giesinger, Monika Sztankay, Sandra Voigt, Lonneke V van de Poll-Franse, Gerhard Rumpold, Roman Weger, Ella Willenbacher, Wolfgang Willenbacher, Bernhard Holzner
Publikováno v:
Journal of Medical Internet Research.
BACKGROUND Use of software to monitor Patient-Reported Outcome Measures (PROMs) can improve outcomes for cancer patients receiving anticancer therapy; however, evidence from applications used in routine clinical practice is lacking. OBJECTIVE We aime
Autor:
Wolfgang Willenbacher, Petra Pichler, Irene Strassl, Maria-Theresa Krauth, Hermine Agis, Siegfried Sormann, Bernd L. Hartmann, Klaus Podar, Roman Weger, Ella Willenbacher
Publikováno v:
Blood. 140:13194-13195
Autor:
Lisa M. Wintner, Roman Weger, Gerhard Rumpold, Wolfgang Willenbacher, Jens Lehmann, Monika Sztankay, Walpurga Weyrer, Bernhard Holzner
Publikováno v:
memo - Magazine of European Medical Oncology. 13:285-293
SummaryPatient-reported outcomes (PROs) have gained increasing importance in oncology. PROs can supplement medical treatment with important information about the patient’s quality of life (QoL), which is typically assessed using standardized questi
Autor:
Andrea Brunner, Wolf Dominik, Wolfgang Willenbacher, Ella Willenbacher, Claudia Manzl, Roman Weger
Publikováno v:
Annals of Hematology
High-grade B cell lymphomas with rearrangements on C-MYC and BCL2 and/or BCL6 (HGBL with MYC and BCL2 and/or Bcl6 rearrangement) are associated with worse clinical outcomes and thus were introduced as a separate new category in the recently updated W
Autor:
Magdalena A. Benda, Hanno Ulmer, Roman Weger, Patrick Reimann, Theresia Lang, Petra Pichler, Thomas Winder, Bernd Hartmann, Irene Strassl, Maria Theresa Krauth, Hermine Agis, Siegfried Sormann, Klaus Podar, Wolfgang Willenbacher, Ella Willenbacher
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 962
Volume 15
Issue 3
Pages: 962
Multiple myeloma (MM) is characterized by serial relapses, necessitating the application of sequential lines of therapy (LoT). Reports on attrition rates (ARs) vary widely. The present study analysed ARs from the Austrian Myeloma Registry. Attrition
Autor:
Ella Willenbacher, Petra Pichler, Irene Strassl, Maria Krauth, Hermine Agis, Sigiegfried Sormann, Bernd Hartmann, Klaus Podar, Roman Weger, Wolfgang Willenbacher
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S193-S194